"Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Hypertension Research

Background:

• Hypertensive nephrosclerosis is a primary driver of end-stage renal disease (ESRD), particularly in Black populations.
• The efficacy of pharmacologic blood pressure reduction to prevent progressive renal failure remains incompletely understood.
• Optimal diastolic blood pressure (DBP) targets for mitigating hypertensive renal injury are not well-established.

Purpose of the Study:

• To investigate whether strict versus conventional blood pressure control impacts the rate of glomerular filtration rate (GFR) decline.
• To compare the long-term effects of intensive DBP management on renal function preservation in hypertensive patients with chronic renal insufficiency.

Main Methods:

• A prospective, randomized trial involving 87 non-diabetic patients with hypertension and chronic renal insufficiency.
• Patients were randomized to either strict (DBP 65-80 mm Hg) or conventional (DBP 85-95 mm Hg) blood pressure control.
• Glomerular filtration rate (GFR) was assessed using 125I-iothalamate clearance, measured serially over time.

Main Results:

• The study aimed to determine the GFR slope (rate of decline) under different blood pressure control strategies.
• Secondary analyses included composite outcomes of GFR reduction, end-stage renal disease (ESRD), and mortality.
• Preliminary data suggest a slower GFR decline in the strict blood pressure control group.

Conclusions:

• Strict blood pressure control, aiming for lower diastolic levels, may be associated with a reduced rate of GFR decline in hypertensive nephrosclerosis.
• These findings support the potential benefit of intensive blood pressure management in preserving kidney function and delaying ESRD progression.
• Further research is warranted to confirm these results and establish definitive treatment guidelines.